Mark Andrew Wilson - Net Worth and Insider Trading
Mark Andrew Wilson Net Worth
The estimated net worth of Mark Andrew Wilson is at least $345,392 dollars as of 2025-01-12. Mark Andrew Wilson is the Chief Legal Officer of Nektar Therapeutics and owns about 335,332 shares of Nektar Therapeutics (NKTR) stock worth over $345,392. Details can be seen in Mark Andrew Wilson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Andrew Wilson has not made any transactions after 2024-12-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Andrew Wilson
Mark Andrew Wilson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Andrew Wilson owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of Mark Andrew Wilson’s form 4 insider trades.
Insider Ownership Summary of Mark Andrew Wilson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2024-12-24 | SVP & General Counsel |
Mark Andrew Wilson Latest Holdings Summary
Mark Andrew Wilson currently owns a total of 1 stock. Mark Andrew Wilson owns 335,332 shares of Nektar Therapeutics (NKTR) as of December 24, 2024, with a value of $345,392.
Latest Holdings of Mark Andrew Wilson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2024-12-24 | 335,332 | 1.03 | 345,392 |
Holding Weightings of Mark Andrew Wilson
Mark Andrew Wilson Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Andrew Wilson has made a total of 21 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Nektar Therapeutics is the sale of 49,962 shares on December 24, 2024, which brought Mark Andrew Wilson around $44,966.
Insider Trading History of Mark Andrew Wilson
- 1
Mark Andrew Wilson Trading Performance
Mark Andrew Wilson Ownership Network
Ownership Network List of Mark Andrew Wilson
Ownership Network Relation of Mark Andrew Wilson
Mark Andrew Wilson Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Mark Andrew Wilson is the SVP & General Counsel of Nektar Therapeutics. Other key executives at Nektar Therapeutics include Chief R&D Officer Jonathan Zalevsky , director & President & CEO Howard W Robin , and director & Executive Chairman Robert Chess .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Mark Andrew Wilson made 7 insider transaction in Nektar Therapeutics (NKTR) with a net sale of 90,286. Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 239,747 shares made by Howard W Robin , a net sale of 101,484 shares made by Jonathan Zalevsky , and a net sale of 56,000 shares made by .
In summary, during the past 3 months, insiders sold 263,577 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 263,577 shares. During the past 18 months, 515,735 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 515,735 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Mark Andrew Wilson Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Andrew Wilson. You might contact Mark Andrew Wilson via mailing address: 1613 Ray Drive, Burlingame Ca 94010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
